127 related articles for article (PubMed ID: 31629608)
21. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.
Kling MA; Alesci S; Csako G; Costello R; Luckenbaugh DA; Bonne O; Duncko R; Drevets WC; Manji HK; Charney DS; Gold PW; Neumeister A
Biol Psychiatry; 2007 Aug; 62(4):309-13. PubMed ID: 17178112
[TBL] [Abstract][Full Text] [Related]
22. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
[TBL] [Abstract][Full Text] [Related]
23. Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder.
Das R; Emon MPZ; Shahriar M; Nahar Z; Islam SMA; Bhuiyan MA; Islam SN; Islam MR
Psychiatry Res; 2021 Jan; 295():113568. PubMed ID: 33199026
[TBL] [Abstract][Full Text] [Related]
24. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.
Cathomas F; Guetter K; Seifritz E; Klaus F; Kaiser S
Sci Rep; 2021 May; 11(1):9992. PubMed ID: 33976271
[TBL] [Abstract][Full Text] [Related]
25. Earlier age of onset is associated with a pro-inflammatory state in major depressive disorder.
Anzolin AP; Feiten JG; Bristot G; Possebon GMP; Fleck MPA; Caldieraro MA; Kauer-Sant'Anna M
Psychiatry Res; 2022 Aug; 314():114601. PubMed ID: 35749859
[TBL] [Abstract][Full Text] [Related]
26. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
27. Cytokine profiles in women with different subtypes of major depressive disorder.
Marques-Deak AH; Neto FL; Dominguez WV; Solis AC; Kurcgant D; Sato F; Ross JM; Prado EB
J Psychiatr Res; 2007; 41(1-2):152-9. PubMed ID: 16375926
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors.
Martins LB; Delevati Colpo G; Calarge CA; Teixeira AL
J Child Adolesc Psychopharmacol; 2021 Aug; 31(6):439-444. PubMed ID: 34166063
[No Abstract] [Full Text] [Related]
29. Serum calcium levels and neuropsychological performance in depression and matched healthy controls: Reversal of correlation a marker of the aging cognitive clock?
Grützner TM; Listunova L; Fabian GA; Kramer BA; Flach D; Weisbrod M; Roesch-Ely D; Sharma A
Psychoneuroendocrinology; 2018 May; 91():198-205. PubMed ID: 29587243
[TBL] [Abstract][Full Text] [Related]
30. Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.
Xiong GL; Prybol K; Boyle SH; Hall R; Streilein RD; Steffens DC; Krishnan R; Rogers JG; O'Connor CM; Jiang W;
Psychosom Med; 2015 Sep; 77(7):808-15. PubMed ID: 26186432
[TBL] [Abstract][Full Text] [Related]
31. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Abbasi SH; Hosseini F; Modabbernia A; Ashrafi M; Akhondzadeh S
J Affect Disord; 2012 Dec; 141(2-3):308-14. PubMed ID: 22516310
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in cognition among Chinese people with Parkinson's disease.
Gao L; Nie K; Tang H; Wang L; Zhao J; Gan R; Huang J; Feng S; Zhu R; Duan Z; Zhang Y; Wang L
J Clin Neurosci; 2015 Mar; 22(3):488-92. PubMed ID: 25595960
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
[TBL] [Abstract][Full Text] [Related]
34. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.
Kahl KG; Bens S; Ziegler K; Rudolf S; Dibbelt L; Kordon A; Schweiger U
Biol Psychiatry; 2006 Apr; 59(7):667-71. PubMed ID: 16199015
[TBL] [Abstract][Full Text] [Related]
35. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
[TBL] [Abstract][Full Text] [Related]
36. Cognitive Impairments in First-Episode Drug-Naïve Versus Medicated Depressive Patients: RBANS in a Chinese Population.
Jia QF; Chen P; Zhu HL; Chen SS; Gu XC; Yin XY; Wu YH; Yin GZ; Hui L
Psychiatr Q; 2019 Sep; 90(3):471-480. PubMed ID: 31079346
[TBL] [Abstract][Full Text] [Related]
37. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
[TBL] [Abstract][Full Text] [Related]
38. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
40. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
